At ACROBiosystems, Dr. Anil Kumar spearheads the team's initiatives of raising awareness and promoting advanced GMP grade solutions for clinical manufacturing of cell and gene therapies. With a PhD in Protein Engineering and over a decade of experience in biopharmaceutical research and development, Anil has been instrumental in leading teams and advancing therapeutic modalities for immune-oncology and auto-immune indications. Prior to joining ACROBiosystems, Anil served as the Director of Antibody Discovery and Protein Engineering at ImmunOs Therapeutics AG. During his tenure, his team played a pivotal role in advancing therapeutic modalities targeting solid tumors, notably placing the lead biologic candidate IOS-1002 for clinical development.